This study is a comparison between Levobupivacaine and Ropivacaine in PNS guided supraclavicular brachial plexus block for upper limb surgeries

Not yet recruiting

• Conditions: COVID 19 virus not identified,

• Registration Number: CTRI/2023/03/050376
• Lead Sponsor: Dr. Yashasvini Lawania

Brief Summary

Various clinical trials have been done on the administration of Levobupivacaine vs Ropivacaine in neuraxial and peripheral nerve blocks for sensory and motor blockade.

However, limited data is available on comparing Levobupivacaine vs Ropivacaine in brachial plexus block. Considering the low side effects and excellent postoperative analgesic efficacy of two drugs, it is essential to carry out a comparative evaluation of the two drugs. To compare the differences in Levobupivacaine and Ropivacaine for supraclavicular brachial plexus block would effect the sensory and motor blocks and duration of analgesia. The present work has been undertaken to study and compare the effect provided by Levobupivacaine vs Ropivacaine in supraclavicular brachial plexus block.

Detailed Description

Not available

Study Timeline

• Last Update Posted: 2023-03-03
• Study Start: 2023-10-03

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

ASA grades 1 And 2 Scheduled for elective upper limb surgeries under supraclavicular brachial plexus block.

Exclusion Criteria

• Patient’s refusal.
• Age <18yrs and >60yrs.
• ASA grade 3 and more.
• History of serious pulmonary disease, ischemic heart disease, renal/hepaticdysfunction, coronary artery, or cervical spine disease and patients with abnormal coagulation profile.
• Patient with h/o opioid abuse.
• Patients with local skin site infections.
• Patients with hypersensitivity to any of the drugs used.
• Pregnant and lactating mothers.
• Failure of Block.
• Restricted neck movement.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To compare the efficacy of 0.5% Levobupivacaine vs 0.75% Ropivacaine in peripheral nerve stimulator guided supraclavicular brachial plexus block in upper limb surgeries	For first 24 hours in 5 mins, 10 mins, 20 mins, 30 mins, 1 hour, 2 hours, 4 hours, 6 hours, 12 hours and 24 hours

Secondary Outcome Measures

Name	Time	Method
To compare the side effects of 0.5% Levobupivacaine vs 0.75% Ropivacaine in peripheral nerve stimulator guided supraclavicular brachial plexus block for upper limb surgeries	First 24 hours in 5 mins, 10 mins, 15 mins, 20 mins, 30 mins, 1 hour, 2 hours, 4 hours, 6 hours, 12 hours and 24 hours

Trial Locations

Locations (1)

Peoples College Of Medical Sciences And Research Centre; 🇮🇳 Bhopal, MADHYA PRADESH, India

Peoples College Of Medical Sciences And Research Centre

🇮🇳Bhopal, MADHYA PRADESH, India

Dr Yashasvini Lawania

Principal investigator

8989615497

yashasvinilawania@gmail.com